Form 4: Algorhythm CEO Atkinson Receives Major Stock Option Grant
Executive Compensation Grant
Algorhythm Holdings, Inc. CEO Gary K. Atkinson was granted 740,597 non-qualified stock options with a $1.84 exercise price, vesting over four years.
Summary
- Gary K. Atkinson, Chief Executive Officer and Director of Algorhythm Holdings, Inc. (RIME), received a grant of 740,597 non-qualified stock options.
- The options have an exercise price of $1.84 per share.
- The grant was made on February 23, 2026, pursuant to Mr. Atkinson's amended and restated employment agreement dated the same day.
- The options were issued under the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan.
- The shares subject to the option will vest and become exercisable in equal quarterly installments over a four-year period, commencing on February 23, 2026.
- The options have an expiration date of February 23, 2036.
Sentiment
Score: 6
Explanation: StockSavvy.ai views this as a neutral to slightly positive event. It's a standard executive compensation action that aligns management incentives, but it doesn't provide new operational or financial performance data.
Positives
- The grant of stock options aligns the Chief Executive Officer's long-term financial interests with those of the shareholders, incentivizing performance.
- The options are part of a formal compensation structure, indicating a structured approach to executive incentives.
Negatives
- The issuance of new stock options represents potential future dilution for existing shareholders if and when the options are exercised.
- The grant will result in future compensation expense for the company, impacting profitability metrics.
Risks
- Potential dilution of existing shareholder equity upon the exercise of the 740,597 stock options.
- The value of the options is tied to the future market price of Algorhythm Holdings, Inc. common stock, which is subject to market volatility and company performance.
- Future compensation expenses related to the vesting of these options will impact the company's financial statements.
Future Outlook
The vesting schedule of the stock options over four years indicates a long-term commitment for the Chief Executive Officer, aligning his incentives with the company's sustained performance over this period.
Industry Context
StockSavvy.ai notes that granting stock options is a common practice in executive compensation across various industries, particularly in technology and growth-oriented companies, to attract, retain, and motivate key leadership by linking their financial success to the company's share price performance.
Comparison to Industry Standards
- Stock options are a standard component of executive compensation packages globally, aiming to align management incentives with shareholder value creation.
- The specific size of the grant (740,597 shares) and the exercise price ($1.84) would typically be benchmarked against peer companies of similar market capitalization, industry, and stage of development to assess competitiveness and fairness.
- While the filing does not provide specific comparable companies, such grants are generally evaluated against industry averages for CEO compensation in companies of similar revenue size and growth profile to ensure they are within reasonable market parameters.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Compensation Plan Utilization | The stock option grant was made pursuant to the Algorhythm Holdings, Inc. 2022 Equity Incentive Plan. | 02/23/2026 | Utilizes an existing shareholder-approved plan to incentivize executive leadership, reinforcing the company's compensation framework. |
| Employment Agreement Update | The grant was made in accordance with Gary K. Atkinson's amended and restated employment agreement. | 02/23/2026 | Indicates a formal review and update of the CEO's employment terms, including compensation. |
Stakeholder Impact
- Shareholders: Potential for future dilution upon exercise of options, but also benefit from aligned management incentives for long-term value creation.
- Employees: The grant to the CEO may set a precedent or context for broader employee incentive programs, though this filing specifically addresses executive compensation.
- Management (Gary K. Atkinson): Receives a significant long-term incentive, directly linking personal wealth to the company's stock performance.
Next Steps
- The stock options will vest in equal quarterly installments over the next four years, commencing February 23, 2026.
- Gary K. Atkinson may choose to exercise the vested options at any point before their expiration date of February 23, 2036.
Key Dates
| Date | Description |
|---|---|
| 02/23/2026 | Date of stock option grant and commencement of vesting period; also the date of the amended and restated employment agreement. |
| 02/25/2026 | Date the Form 4 was signed by Gary Atkinson. |
| 02/23/2036 | Expiration date of the non-qualified stock options. |
Recommendation
holdThis Form 4 reports a routine executive compensation grant, which is a standard practice to align management incentives. It does not contain information that would fundamentally alter the investment thesis for Algorhythm Holdings, Inc. A seasoned investor would likely maintain their current position, awaiting more substantive operational or financial updates.
Keywords
Algorhythm Holdings, RIME, Stock Options, Executive Compensation, Gary Atkinson, Form 4, Equity Incentive Plan, CEO Compensation, Non-qualified Stock Option
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.